488 related articles for article (PubMed ID: 19540111)
1. Discovery of novel 2-(pyridine-2-yl)-1H-benzimidazole derivatives as potent glucokinase activators.
Ishikawa M; Nonoshita K; Ogino Y; Nagae Y; Tsukahara D; Hosaka H; Maruki H; Ohyama S; Yoshimoto R; Sasaki K; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem Lett; 2009 Aug; 19(15):4450-4. PubMed ID: 19540111
[TBL] [Abstract][Full Text] [Related]
2. The design and optimization of a series of 2-(pyridin-2-yl)-1H-benzimidazole compounds as allosteric glucokinase activators.
Takahashi K; Hashimoto N; Nakama C; Kamata K; Sasaki K; Yoshimoto R; Ohyama S; Hosaka H; Maruki H; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem; 2009 Oct; 17(19):7042-51. PubMed ID: 19736020
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent and orally active 3-alkoxy-5-phenoxy-N-thiazolyl benzamides as novel allosteric glucokinase activators.
Iino T; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Hasegawa T; Chiba M; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem; 2009 Apr; 17(7):2733-43. PubMed ID: 19282189
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel 3,6-disubstituted 2-pyridinecarboxamide derivatives as GK activators.
Mitsuya M; Kamata K; Bamba M; Watanabe H; Sasaki Y; Sasaki K; Ohyama S; Hosaka H; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem Lett; 2009 May; 19(10):2718-21. PubMed ID: 19362831
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and SAR of novel glucokinase activators.
Cheruvallath ZS; Gwaltney SL; Sabat M; Tang M; Feng J; Wang H; Miura J; Guntupalli P; Jennings A; Hosfield D; Lee B; Wu Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):2166-71. PubMed ID: 23434031
[TBL] [Abstract][Full Text] [Related]
6. 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators.
Zhang L; Rogers BN; Duplantier AJ; McHardy SF; Efremov I; Berke H; Qian W; Zhang AQ; Maklad N; Candler J; Doran AC; Lazzaro JT; Ganong AH
Bioorg Med Chem Lett; 2008 Oct; 18(20):5493-6. PubMed ID: 18812259
[TBL] [Abstract][Full Text] [Related]
7. Structure-based design and synthesis of benzimidazole derivatives as dipeptidyl peptidase IV inhibitors.
Wallace MB; Feng J; Zhang Z; Skene RJ; Shi L; Caster CL; Kassel DB; Xu R; Gwaltney SL
Bioorg Med Chem Lett; 2008 Apr; 18(7):2362-7. PubMed ID: 18346892
[TBL] [Abstract][Full Text] [Related]
8. SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.
Bertram LS; Black D; Briner PH; Chatfield R; Cooke A; Fyfe MC; Murray PJ; Naud F; Nawano M; Procter MJ; Rakipovski G; Rasamison CM; Reynet C; Schofield KL; Shah VK; Spindler F; Taylor A; Turton R; Williams GM; Wong-Kai-In P; Yasuda K
J Med Chem; 2008 Jul; 51(14):4340-5. PubMed ID: 18588279
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 3-(4-methanesulfonylphenoxy)-N-[1-(2-methoxy-ethoxymethyl)-1H-pyrazol-3-yl]-5-(3-methylpyridin-2-yl)-benzamide as a novel glucokinase activator (GKA) for the treatment of type 2 diabetes mellitus.
Park K; Lee BM; Hyun KH; Lee DH; Choi HH; Kim H; Chong W; Kim KB; Nam SY
Bioorg Med Chem; 2014 Apr; 22(7):2280-93. PubMed ID: 24588963
[TBL] [Abstract][Full Text] [Related]
10. Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.
Iino T; Sasaki Y; Bamba M; Mitsuya M; Ohno A; Kamata K; Hosaka H; Maruki H; Futamura M; Yoshimoto R; Ohyama S; Sasaki K; Chiba M; Ohtake N; Nagata Y; Eiki J; Nishimura T
Bioorg Med Chem Lett; 2009 Oct; 19(19):5531-8. PubMed ID: 19726182
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel and potent 2-amino benzamide derivatives as allosteric glucokinase activators.
Nishimura T; Iino T; Mitsuya M; Bamba M; Watanabe H; Tsukahara D; Kamata K; Sasaki K; Ohyama S; Hosaka H; Futamura M; Nagata Y; Eiki J
Bioorg Med Chem Lett; 2009 Mar; 19(5):1357-60. PubMed ID: 19188063
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vivo antihyperglycemic activity of nature-mimicking furanyl-2-pyranones in STZ-S model.
Singh FV; Chaurasia S; Joshi MD; Srivastava AK; Goel A
Bioorg Med Chem Lett; 2007 May; 17(9):2425-9. PubMed ID: 17336063
[TBL] [Abstract][Full Text] [Related]
13. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
[TBL] [Abstract][Full Text] [Related]
14. Novel glucokinase activators: a patent review (2008 - 2010).
Sarabu R; Berthel SJ; Kester RF; Tilley JW
Expert Opin Ther Pat; 2011 Jan; 21(1):13-33. PubMed ID: 21155690
[TBL] [Abstract][Full Text] [Related]
15. Derivatives of benzimidazole pharmacophore: synthesis, anticonvulsant, antidiabetic and DNA cleavage studies.
Shingalapur RV; Hosamani KM; Keri RS; Hugar MH
Eur J Med Chem; 2010 May; 45(5):1753-9. PubMed ID: 20122763
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel thiazol-2-yl benzamide derivatives as glucokinase activators.
Charaya N; Pandita D; Grewal AS; Lather V
Comput Biol Chem; 2018 Apr; 73():221-229. PubMed ID: 29518630
[TBL] [Abstract][Full Text] [Related]
17. Small molecule glucokinase activators as novel anti-diabetic agents.
Leighton B; Atkinson A; Coghlan MP
Biochem Soc Trans; 2005 Apr; 33(Pt 2):371-4. PubMed ID: 15787609
[TBL] [Abstract][Full Text] [Related]
18. Identification of a new class of glucokinase activators through structure-based design.
Hinklin RJ; Boyd SA; Chicarelli MJ; Condroski KR; DeWolf WE; Lee PA; Lee W; Singh A; Thomas L; Voegtli WC; Williams L; Aicher TD
J Med Chem; 2013 Oct; 56(19):7669-78. PubMed ID: 24015910
[TBL] [Abstract][Full Text] [Related]
19. Design of a potent, soluble glucokinase activator with increased pharmacokinetic half-life.
Pike KG; Allen JV; Caulkett PW; Clarke DS; Donald CS; Fenwick ML; Johnson KM; Johnstone C; McKerrecher D; Rayner JW; Walker RP; Wilson I
Bioorg Med Chem Lett; 2011 Jun; 21(11):3467-70. PubMed ID: 21515051
[TBL] [Abstract][Full Text] [Related]
20. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.
Matschinsky FM; Zelent B; Doliba NM; Kaestner KH; Vanderkooi JM; Grimsby J; Berthel SJ; Sarabu R
Handb Exp Pharmacol; 2011; (203):357-401. PubMed ID: 21484579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
